Literature DB >> 13412741

Studies of bacterial resistance to 6-azauracil and its riboside.

R E HANDSCHUMACHER.   

Abstract

Entities:  

Keywords:  BACTERIA/effect of drugs on; HETEROCYCLIC COMPOUNDS/effects

Mesh：

Substances：

Year:  1957        PMID： 13412741     DOI： 10.1016/0006-3002(57)90348-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  7 in total

1.  The anti-tumour activity of 6-azauracil riboside.

Authors:  F SORM; H KEILOVA
Journal:  Experientia       Date:  1958-06-15

2.  Incorporation of Exogenous Purines and Pyrimidines by Methanococcus voltae and Isolation of Analog-Resistant Mutants.

Authors:  T L Bowen; W B Whitman
Journal:  Appl Environ Microbiol       Date:  1987-08       Impact factor: 4.792

Review 3.  New indications for 6-azauridine treatment in man. A review.

Authors:  J Elis; H Rasková
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

Review 4.  Pyrimidine metabolism in microorganisms.

Authors:  G A O'Donovan; J Neuhard
Journal:  Bacteriol Rev       Date:  1970-09

5.  Effects of uracil and thymidine on the development of resistance to 5-fluorouracil in Pediococcus cerevisiae.

Authors:  P J WHITE; C A NICHOL
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

6.  Enzymatic synthesis and phosphorolysis of 4(2)-thioxo- and 6(5)-azapyrimidine nucleosides by E. coli nucleoside phosphorylases.

Authors:  Vladimir A Stepchenko; Anatoly I Miroshnikov; Frank Seela; Igor A Mikhailopulo
Journal:  Beilstein J Org Chem       Date:  2016-12-01       Impact factor: 2.883

7.  Studies on the carcinostatic activity in mice of 6-azauracil riboside (azauridine), in comparison with that of 6-azauracil.

Authors:  J J JAFFE; R E HANDSCHUMACHER; A D WELCH
Journal:  Yale J Biol Med       Date:  1957-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.